NCT05331443

Brief Summary

Include participants who intend to practice Ramadan fasting and accept to complete the three part of the study .

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
250

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2022

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 15, 2022

Completed
27 days until next milestone

First Submitted

Initial submission to the registry

April 11, 2022

Completed
4 days until next milestone

First Posted

Study publicly available on registry

April 15, 2022

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2023

Completed
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 15, 2024

Completed
Last Updated

November 18, 2023

Status Verified

November 1, 2023

Enrollment Period

1.2 years

First QC Date

April 11, 2022

Last Update Submit

November 16, 2023

Conditions

Keywords

Ramadan FastingEndo-pat

Outcome Measures

Primary Outcomes (1)

  • Change in Reactive Hyperemia Index (RHI)

    RHI is calculated for each participant in the day of iclusion , then it is recalculated in the two others visits.

    the day of inclusion , 10 last day of Ramadan , 1 month after Ramadan

Study Arms (1)

participents who has the intention to fast Ramadan

subjects with at least two cardiovascular risk factors according to Framingham classification or with out any risk .

Diagnostic Test: Reactive hyperemia-peripheral arterial tonometry Index (RHI )

Interventions

RHI was assessed by RH-PAT using the EndoPAT2000 system .

participents who has the intention to fast Ramadan

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Stable patients that intend to fast Ramadan. Each participant is examined during three planned visits. The first takes place during the month preceding Ramadan. The second during the last week of Ramadan and the third thirty days after the end of Ramadan. Participants that miss one appointement or more are exluded from the study. Patient recrutement is conducted in primary care centers of the state of Monastir, out-patient clinic (Cardiology, Endocrinology) at the emergency department of Fattouma Bourguiba university hospital after a clarified written consent.

You may qualify if:

  • Adult patient intending to fast Ramadan.

You may not qualify if:

  • Age \< 18 years old
  • Hemodynamic instability.
  • Myocardial infarction requiring urgent revascularization.
  • Parkinsonism: tremor problem.
  • Refusal, communication problem.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University hospital Fattouma Bourguiba

Monastir, 5000, Tunisia

Location

MeSH Terms

Conditions

Fasting

Condition Hierarchy (Ancestors)

Feeding BehaviorBehavior

Study Officials

  • Semir Nouira, Professor

    University of Monastir

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
3 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

April 11, 2022

First Posted

April 15, 2022

Study Start

March 15, 2022

Primary Completion

May 30, 2023

Study Completion

July 15, 2024

Last Updated

November 18, 2023

Record last verified: 2023-11

Locations